Loading clinical trials...

Multi-centric Study | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01219816

Multi-centric Study

Patients with relapsed/refractory adult acute lymphoblastic leukemia (ALL)have a very dismal prognosis. In this case, allogeneic transplantation is the only curative treatment when patient have obtain...

Lead sponsor: Nantes University Hospital•11 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

UNKNOWNNA

Denosumab vs Alendronate After Vertebroplasty

NCT05662358 · Denosumab Allergy

COMPLETEDPhase 4

Denosumab vs Zoledronate After Vertebroplasty

NCT05598606 · Denosumab Allergy, Zoledronic Acid Allergy

UNKNOWNPhase 1

CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL

NCT05270772 · CD19+ Relapse/Refractory B-ALL

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 27, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment57

Start dateNov 2010

Last updatedFeb 27, 2018

Condition

B ALL CD22+ Expression Refractory B-ALL

Locations shown

Angers University Hospital

Angers

University Hospital

Caen

HEnri Mondor Hospital

Créteil

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 27, 2018Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions